Pfizer Inc.PFENYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-7.6%
5Y CAGR-14.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-7.6%/yr
vs -10.8%/yr prior
5Y CAGR
-14.4%/yr
Recent acceleration
Acceleration
+3.2pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
6 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.26 | -4.3% |
| 2024 | 2.36 | -13.4% |
| 2023 | 2.73 | -4.8% |
| 2022 | 2.86 | -29.6% |
| 2021 | 4.07 | -17.1% |
| 2020 | 4.91 | -2.3% |
| 2019 | 5.02 | +10.9% |
| 2018 | 4.53 | +16.1% |
| 2017 | 3.90 | +9.9% |
| 2016 | 3.55 | - |